Announce the Company's Board of Directors
approved the consolidated financial statements
for the period ended June 30, 2022.
Date of events
2022/08/10
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/08/10
2.Date of approval by the audit committee:2022/08/08
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,909,833
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,848,889
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):452,990
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):664,376
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):507,956
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):498,836
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.87
11.Total assets end of the period (thousand NTD):12,064,486
12.Total liabilities end of the period
(thousand NTD):5,385,331
13.Equity attributable to owners of parent end of the
period (thousand NTD):6,585,808
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
YungShin Global Holding Corporation published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 09:46:01 UTC.
YungShin Global Holding Corp is a Taiwan-based company mainly engaged in the manufacture and sale of human pharmaceutical medicine and animal medicine. The Company mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The Company also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.